ADHD Assessment & Psychiatry Clinic Dubai by German Diagnostics

ADHD Medication for Adults in Dubai

ADHD medication for adults in Dubai includes methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse) and the non-stimulant atomoxetine (Strattera). A licensed psychiatrist in Dubai compares them with you and prescribes the medicine that fits your day, your health and UAE rules.

Already on ADHD medication from abroad? The psychiatrist reviews your current treatment and continues it with a UAE prescription.

Prescription pad, pill bottle and weekly pill organiser for ADHD medication for adults in Dubai

In short

  • Three ADHD medicines for adults have UAE brand names: methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse) and atomoxetine (Strattera, Apo atomoxetine).
  • Methylphenidate and lisdexamfetamine are controlled medicines (Psychotropic Schedule II). Atomoxetine is not on the Emirates Drug Establishment controlled list.
  • Stimulants are the first-line medicines for most adults. In 11 trials with 1,991 adults, Cohen's d was 0.67 for stimulants and 0.59 for non-stimulants.
  • In 51 trials with 8,131 adults, amphetamines reduced symptoms slightly more than methylphenidate (SMD -0.29), with more dropouts from side effects.
  • Before the first prescription, the psychiatrist checks heart history, blood pressure and pulse, and adds an ECG with heart symptoms.
  • Medication combined with cognitive behavioural therapy (CBT) is the preferred first treatment for most adults with ADHD.
No diagnosis yet? Start with the free 2-minute ADHD test.
6 WHO questions, your score in 2 minutes, no sign-up.
Take the free test ›

Which ADHD medication can adults get in Dubai?

Adults in Dubai can get methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse) and atomoxetine (Strattera) with a prescription from a UAE-licensed psychiatrist. Methylphenidate and lisdexamfetamine are controlled medicines, so they are prescribed only after a confirmed diagnosis and a health check.

The psychiatrist chooses the medicine with you, based on how long you need the effect each day, your heart health, other conditions and earlier experience with ADHD medicines.

No diagnosis yet? Start with an adult ADHD assessment in Dubai.

Bring:

Psychiatrist showing an ADHD medication plan for adults on a tablet in Dubai

ADHD medicines for adults compared

The table lists the ADHD medicines for adults, their brand names in the UAE, how fast they act and their status on the Emirates Drug Establishment list.

ADHD medicines for adults in the UAE compared
MedicineBrand names in the UAETypeOnset and durationUAE status
MethylphenidateRitalin (short-acting), Concerta (long-acting)StimulantSame day. Short-acting 3 to 5 hours, long-acting 8 to 12 hours or morePsychotropic Schedule II
LisdexamfetamineVyvanseStimulant, amphetamine group20 to 60 minutes. Lasts about 10 to 12 hoursPsychotropic Schedule II
AtomoxetineStrattera, Apo atomoxetineNon-stimulantFull effect after up to 4 weeks. One dose lasts up to 24 hoursNot on the controlled list
Mixed amphetamine saltsNo UAE brand listed (Adderall abroad)Stimulant, amphetamine group20 to 60 minutes. Up to 6 hours, long-acting 10 to 12 hoursAmfetamine is Psychotropic Schedule II
GuanfacineNo UAE brand listed (Intuniv abroad)Non-stimulantNot applicable in the UAENo UAE brand listed

Sources: Emirates Drug Establishment list (2022), international drug references and product information.

Which ADHD medication works best for adults?

Stimulants reduce ADHD symptoms in adults more than non-stimulants. In a meta-analysis of 11 trials with 1,991 adults (MĂ©száros 2009), Cohen’s d was 0.67 for stimulants and 0.59 for non-stimulants, a medium effect for both.

A network meta-analysis of 51 trials with 8,131 adults (Cortese, Lancet Psychiatry 2018) found that amphetamines reduced symptoms slightly more than methylphenidate after about 12 weeks (SMD -0.29). More adults stopped amphetamines because of side effects.

Short-acting or long-acting ADHD medication?

Short-acting and long-acting stimulants work equally well in adults. Short-acting forms cover a chosen part of the day, such as a meeting or a lecture. Long-acting forms cover most of the day with one dose and are less likely to be misused.

Stimulant or non-stimulant?

A stimulant is the first choice for most adults with ADHD, because the effect starts on the first day. Atomoxetine, a non-stimulant, reaches its full effect after up to 4 weeks. Atomoxetine is the first choice after a substance use disorder, because it has little to no potential for misuse. More in Strattera prescription in Dubai.

What are the common side effects?

Common side effects of stimulants in adults are dry mouth, poor appetite, weight loss, sleep problems, irritability and headaches. Blood pressure rises by about 3 to 5 mmHg and heart rate by about 5 beats per minute on average. Across studies, about 10 percent of adults stop stimulants because of side effects.

What does ADHD medication change in daily life?

In a Swedish registry study of 148,581 people with ADHD (Zhang, BMJ 2024), starting ADHD medication was linked over two years to fewer first episodes of suicidal behaviour (15 versus 17 percent), substance misuse (59 versus 69 percent) and criminal convictions (65 versus 76 percent). In the same cohort, ADHD medication was linked to lower all-cause mortality (hazard ratio 0.79) (Li, JAMA 2024).

How a psychiatrist chooses your ADHD medication

The psychiatrist starts with a low dose and raises it about weekly, with monthly check-ups until the dose is stable. Other conditions change the order of treatment.

ADHD with depression

Bupropion (Wellbutrin in the UAE), an antidepressant, treats depression and ADHD at the same time and is the usual first choice when both are present.

ADHD with anxiety

The anxiety is treated first with an SSRI or SNRI antidepressant. A stimulant follows once the anxiety improves, with monitoring for serotonin syndrome, a rare reaction to too much serotonin.

ADHD with bipolar disorder

Mood is stabilised with a mood stabiliser before ADHD treatment starts. In a Swedish registry study, methylphenidate without a mood stabiliser was linked to mania (hazard ratio 6.7), but not with one.

Pregnancy and travel

Pregnancy plans are part of the decision, see ADHD assessment for women in Dubai. For flights with ADHD medication, see Taking ADHD medication to Dubai and ADHD medication during Ramadan.

Frequently asked questions about ADHD medication for adults in Dubai

Short answers about options, rules and check-ups.

Methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse) and atomoxetine (Strattera, Apo atomoxetine) have UAE brand names. A UAE-licensed psychiatrist prescribes them after a confirmed diagnosis.

Adderall has no UAE brand name in international drug references, and amfetamine is a Psychotropic Schedule II medicine in the UAE. More in Adderall prescription in Dubai.

Stimulants work best for most adults. In 51 trials with 8,131 adults, amphetamines reduced symptoms slightly more than methylphenidate, with more dropouts from side effects. The best medicine depends on your health and your day.

Yes, atomoxetine (Strattera) is the non-stimulant ADHD medicine sold in the UAE. More in Strattera prescription in Dubai.

Yes, a UAE-licensed psychiatrist reviews your diagnosis and current medicine and issues a UAE prescription. If your medicine is not available here, you switch to the closest option together.

About once a month until the dose is stable, with blood pressure and pulse at each visit, and less often afterwards.

Yes, ADHD medication follows a confirmed diagnosis. Without one, the first step is an adult ADHD assessment in Dubai.

Book your appointment

Two fields are enough, because a short call settles more than a long form. Prefer to write? WhatsApp reaches the clinic phone directly.

Request an appointment

    We reply within clinic hours. Your details are used only to answer your enquiry.

    Sources

    • Emirates Drug Establishment, controlled and semi-controlled medicines list (updated 15 September 2022)
    • Eli Lilly Gulf, Strattera product labels for the UAE and the Gulf region
    • MĂ©száros A, et al. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009.
    • Cortese S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018.
    • Li L, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA 2024.
    • Zhang L, et al. ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials. BMJ 2024.
    • Viktorin A, et al. The risk of treatment-emergent mania with methylphenidate in bipolar disorder. American Journal of Psychiatry 2017.
    • Cherkasova MV, et al. Efficacy of cognitive behavioral therapy with and without medication for adults with ADHD: a randomized clinical trial. J Atten Disord 2020.
    Scroll to Top